These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 24831809

  • 21. If channel blocker ivabradine vs. β-blockers for sinus tachycardia in patients with takotsubo syndrome.
    Madias JE.
    Int J Cardiol; 2016 Nov 15; 223():877-878. PubMed ID: 27584563
    [No Abstract] [Full Text] [Related]

  • 22. Emerging role of ivabradine for rate control in atrial fibrillation.
    Turley SL, Francis KE, Lowe DK, Cahoon WD.
    Ther Adv Cardiovasc Dis; 2016 Dec 15; 10(6):348-352. PubMed ID: 27659287
    [Abstract] [Full Text] [Related]

  • 23. Cardioprotection by ivabradine through heart rate reduction and beyond.
    Heusch G, Skyschally A, Schulz R.
    J Cardiovasc Pharmacol Ther; 2011 Dec 15; 16(3-4):281-4. PubMed ID: 21821529
    [Abstract] [Full Text] [Related]

  • 24. Ivabradine in acute coronary syndromes: Protection beyond heart rate lowering.
    Niccoli G, Borovac JA, Vetrugno V, Camici PG, Crea F.
    Int J Cardiol; 2017 Jun 01; 236():107-112. PubMed ID: 28256323
    [Abstract] [Full Text] [Related]

  • 25. [Heart rate reduction due to selective specific inhibition of the If current opens new possibilities in treatment of basic cardiovascular diseases].
    Chichkanov GG, Tsorin IB.
    Eksp Klin Farmakol; 2013 Jun 01; 76(2):37-42. PubMed ID: 23631283
    [Abstract] [Full Text] [Related]

  • 26. Comparison of a beta-blocker and an If current inhibitor in rabbits with myocardial infarction.
    Langenbach MR, Schmitz-Spanke S, Brockert M, Schepan M, Pomblum VJ, Gams E, Zirngibl H, Schipke JD.
    J Cardiovasc Surg (Torino); 2006 Dec 01; 47(6):719-25. PubMed ID: 17043621
    [Abstract] [Full Text] [Related]

  • 27. Cardiac pacemaker I(f) current and its inhibition by heart rate-reducing agents.
    DiFrancesco D.
    Curr Med Res Opin; 2005 Jul 01; 21(7):1115-22. PubMed ID: 16004681
    [Abstract] [Full Text] [Related]

  • 28. Ivabradine in chronic stable angina: Effects by and beyond heart rate reduction.
    Camici PG, Gloekler S, Levy BI, Skalidis E, Tagliamonte E, Vardas P, Heusch G.
    Int J Cardiol; 2016 Jul 15; 215():1-6. PubMed ID: 27104917
    [Abstract] [Full Text] [Related]

  • 29. Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial.
    Kosmala W, Holland DJ, Rojek A, Wright L, Przewlocka-Kosmala M, Marwick TH.
    J Am Coll Cardiol; 2013 Oct 08; 62(15):1330-8. PubMed ID: 23916925
    [Abstract] [Full Text] [Related]

  • 30. Preclinical results with I(f) current inhibition by ivabradine.
    Berdeaux A.
    Drugs; 2007 Oct 08; 67 Suppl 2():25-33. PubMed ID: 17999561
    [Abstract] [Full Text] [Related]

  • 31. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study.
    Swedberg K, Komajda M, Böhm M, Borer J, Robertson M, Tavazzi L, Ford I, SHIFT Investigators.
    J Am Coll Cardiol; 2012 May 29; 59(22):1938-45. PubMed ID: 22617188
    [Abstract] [Full Text] [Related]

  • 32. Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial).
    Böhm M, Robertson M, Ford I, Borer JS, Komajda M, Kindermann I, Maack C, Lainscak M, Swedberg K, Tavazzi L.
    Am J Cardiol; 2015 Dec 15; 116(12):1890-7. PubMed ID: 26508709
    [Abstract] [Full Text] [Related]

  • 33. Review of the If selective channel inhibitor ivabradine in the treatment of chronic stable angina.
    Prasad UK, Gray D, Purcell H.
    Adv Ther; 2009 Feb 15; 26(2):127-37. PubMed ID: 19259630
    [Abstract] [Full Text] [Related]

  • 34. β-Blockers and ivabradine differentially affect cardiopulmonary function and left ventricular filling index.
    Fischer-Rasokat U, Honold J, Lochmann D, Wolter S, Liebetrau C, Fichtlscherer S, Möllmann H, Spyridopoulos I, Hamm CW.
    Clin Res Cardiol; 2016 Jun 15; 105(6):527-34. PubMed ID: 26687495
    [Abstract] [Full Text] [Related]

  • 35. Ivabradine: A Unique and Intriguing Medication for Treating Cardiovascular Disease.
    Nawarskas JJ, Bowman BN, Anderson JR.
    Cardiol Rev; 2015 Jun 15; 23(4):201-11. PubMed ID: 25839989
    [Abstract] [Full Text] [Related]

  • 36. Effect of ivabradine on left ventricular remodelling after reperfused myocardial infarction: A pilot study.
    Gerbaud E, Montaudon M, Chasseriaud W, Gilbert S, Cochet H, Pucheu Y, Horovitz A, Bonnet J, Douard H, Coste P.
    Arch Cardiovasc Dis; 2014 Jan 15; 107(1):33-41. PubMed ID: 24440004
    [Abstract] [Full Text] [Related]

  • 37. Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine : MODI (f)Y trial.
    Nuding S, Ebelt H, Hoke RS, Krummenerl A, Wienke A, Müller-Werdan U, Werdan K.
    Clin Res Cardiol; 2011 Oct 15; 100(10):915-23. PubMed ID: 21638157
    [Abstract] [Full Text] [Related]

  • 38. Heart rate reduction with ivabradine improves energy metabolism and mechanical function of isolated ischaemic rabbit heart.
    Ceconi C, Cargnoni A, Francolini G, Parinello G, Ferrari R.
    Cardiovasc Res; 2009 Oct 01; 84(1):72-82. PubMed ID: 19477966
    [Abstract] [Full Text] [Related]

  • 39. Heart rate reduction: a potential target for the treatment of myocardial ischaemia.
    Danchin N, Aly S.
    Therapie; 2004 Oct 01; 59(5):511-5. PubMed ID: 15648303
    [Abstract] [Full Text] [Related]

  • 40. Characterization of the heart rate-lowering action of ivabradine, a selective I(f) current inhibitor.
    Borer JS, Le Heuzey JY.
    Am J Ther; 2008 Oct 01; 15(5):461-73. PubMed ID: 18806523
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.